Airway Inflammation and Host Responses in the Era of CFTR Modulators

The arrival of cystic fibrosis transmembrane conductance regulator (CFTR) modulators as a new class of treatment for cystic fibrosis (CF) in 2012 represented a pivotal advance in disease management, as these small molecules directly target the upstream underlying protein defect. Further advancements...

Descripción completa

Detalles Bibliográficos
Autores principales: Keown, Karen, Brown, Ryan, Doherty, Declan F., Houston, Claire, McKelvey, Michael C., Creane, Shannice, Linden, Dermot, McAuley, Daniel F., Kidney, Joseph C., Weldon, Sinéad, Downey, Damian G., Taggart, Clifford C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504341/
https://www.ncbi.nlm.nih.gov/pubmed/32887484
http://dx.doi.org/10.3390/ijms21176379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504341/
https://www.ncbi.nlm.nih.gov/pubmed/32887484
http://dx.doi.org/10.3390/ijms21176379

Ejemplares similares